The pharmacy benefit landscape is shifting. With rising costs, limited transparency, and rigid structures imposed by legacy pharmacy benefit managers (PBMs), organizations are considering a bold ...

The Pioneer Institute recently released a study raising concern over the lack of transparency around the role pharmacy ...

While policymakers should try to increase pharmacy benefit manager competition and PBM transparency, it probably won't have much effect on U.S. prescription drug costs, according to Matthew Fiedler.

Federal lawmakers say bipartisan legislation will provide greater transparency of PBM practices and help with high drug costs. RELATED STORIES: ‘Driven out by middlemen’: Pharmacists across ...

H.R.5391, S. 2764 - Protecting Patient Access to Cancer and Complex Therapies Act H.R.2880 - Protecting Patients Against PBM Abuses Act Issues related to reforming and increasing transparency within ...